1. miR-4716–3p and the target AKT2 Gene/rs2304186 SNP are associated with blood cancer pathogenesis in Pakistani population
    Jairus Olumasai Nandwa et al, 2024, Non-coding RNA Research CrossRef
  2. RLN2 Is a Positive Regulator of AKT-2-Induced Gene Expression Required for Osteosarcoma Cells Invasion and Chemoresistance
    Jinfeng Ma et al, 2015, BioMed Research International CrossRef
  3. Profiling of three H3F3A-mutated and denosumab-treated giant cell tumors of bone points to diverging pathways during progression and malignant transformation
    Marc Hasenfratz et al, 2021, Scientific Reports CrossRef
  4. MiR-200c regulates tumor growth and chemosensitivity to cisplatin in osteosarcoma by targeting AKT2
    Yang Liu et al, 2017, Scientific Reports CrossRef
  5. Analyzing the Interactions of mRNAs and ncRNAs to Predict Competing Endogenous RNA Networks in Osteosarcoma Chemo-Resistance
    Kun-Peng Zhu et al, 2019, Molecular Therapy CrossRef
  6. A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis
    Branden S Moriarity et al, 2015, Nature Genetics CrossRef
  7. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma
    Yining Lu et al, 2024, Scientific Reports CrossRef
  8. Triangle of AKT2, miRNA, and Tumorigenesis in Different Cancers
    Maryam Honardoost et al, 2018, Applied Biochemistry and Biotechnology CrossRef
  9. 5,7-Dihydroxy-4′-methoxyisoflavone induces apoptosis by inhibiting the ERK and Akt pathways in human osteosarcoma cells
    Xiaosheng Lu et al, 2015, Connective Tissue Research CrossRef
  10. A 2D-QSAR and Grid-Independent Molecular Descriptor (GRIND) Analysis of Quinoline-Type Inhibitors of Akt2: Exploration of the Binding Mode in the Pleckstrin Homology (PH) Domain
    Noreen Akhtar et al, 2016, PLOS ONE CrossRef
  11. AKT2 drives cancer progression and is negatively modulated by miR-124 in human lung adenocarcinoma
    Ting Liu et al, 2020, Respiratory Research CrossRef
  12. Costunolide, an active sesquiterpene lactone, induced apoptosis via ROS-mediated ER stress and JNK pathway in human U2OS cells
    Chao Zhang et al, 2016, Biomedicine & Pharmacotherapy CrossRef
  13. Receptor activator of nuclear factor κB expression is a prognostic factor in human osteosarcoma
    KLEMENS TRIEB et al, 2015, Oncology Letters CrossRef
  14. Ectopic Expression of Ankrd2 Affects Proliferation, Motility and Clonogenic Potential of Human Osteosarcoma Cells
    Manuela Piazzi et al, 2021, Cancers CrossRef
  15. AKT2 identified as a potential target of mir-29a-3p via microRNA profiling of patients with high proliferation lacrimal gland adenoid cystic carcinoma
    Jinzhi Zhao et al, 2022, Experimental Eye Research CrossRef
  16. Downregulation of Homeobox B7 Inhibits the Tumorigenesis and Progression of Osteosarcoma
    Lei Yang et al, 2017, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
  17. Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario
    Marina Ferreira Candido et al, 2023, Pharmaceutics CrossRef
  18. A liquid biopsy-based method for the detection and quantification of circulating tumor cells in surgical osteosarcoma patients
    Haoqiang Zhang et al, 2017, International Journal of Oncology CrossRef
  19. Induction of apoptosis in ovarian cancer cells by miR-493-3p directly targeting AKT2, STK38L, HMGA2, ETS1 and E2F5
    Michael Kleemann et al, 2019, Cellular and Molecular Life Sciences CrossRef
  20. Ferroptosis-related lncRNAs guiding osteosarcoma prognosis and immune microenvironment
    Mingyi Yang et al, 2023, Journal of Orthopaedic Surgery and Research CrossRef